Webcast: Portfolio analysis - Go/No-go decisions
When a pharma company is either considering acquiring a new agent, or developing one in-house, marketers need to understand the impact on the overall portfolio and decide whether to make a go or no-go decision on that asset. Watch this webcast in which Research Partnership's Pei Li Teh and Callum McCulloch (who are both from our Singapore office) discuss how market research insights allow you to make confident go/no-go decisions in portfolio planning.
Webcast: Portfolio analysis - Tracking for success
Portfolio Analysis and Optimization looks at how honing strategy across multiple agents in the same therapeutic category leads to marketing success. As pharmaceutical companies simultaneously develop and in-license multiple products that can cost millions of dollars, portfolio management is about selecting how to allocate resources and marketing efforts across multiple assets. This has significant impact on the bottom line.
Communication trends in Latin America: How pharma can utilise new and emerging digital platforms
Smartphones and digital technology have revolutionised the way we communicate with one another. Latin America, like other parts of the world, has been swift to embrace new and emerging digital applications, in particular WhatsApp, which has become an ubiquitous tool for people in both their personal lives and in business. As digital communication channels increase in popularity, it is important for the pharmaceutical industry to keep in step. Understanding how to leverage platforms like WhatsApp as both a means of generating customer insight and as a stakeholder engagement tool, will help pharma companies to have impact in this exciting and ever-changing region.
Webcast: Portfolio analysis - Choosing your communication strategy
Portfolio Analysis and Optimization concentrates on determining the impact that multiple assets have within therapeutic categories, and how the marketing of these assets impacts on overall strategy. This is an important tool for pharmaceutical companies in today’s market. As they simultaneously develop multiple products that can become extremely costly, portfolio management to improve decision-making can have a significant impact on the bottom line. At its very core, it is about selecting how to allocate resources and marketing efforts across multiple assets.
Harnessing the power of social: How to generate fresh insights for your business using social media listening
Given the colossal amount of personal and professional information that we share online, social media channels are fast becoming treasure troves of big data. As the popularity and diversity of platforms increases, so too does their utility for healthcare market research. With a continuous stream of user-generated content, advances in research technology allow marketers to tap into social media data to understand more about the healthcare landscape.